RNGTT
MOLECULAR TARGETRNA guanylyltransferase and 5'-phosphatase
RNGTT (RNA guanylyltransferase and 5'-phosphatase) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting RNGTT
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | molibresib | 3.81 | 44 |
| 2 | Levamisole | 0.69 | 1 |
About RNGTT as a Drug Target
RNGTT (RNA guanylyltransferase and 5'-phosphatase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented RNGTT interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
RNGTT inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.